Improving family history screening for BRCA-related cancers in rural clinics
Evaluating an evidence-based family history screening program adapted to increase reach and uptake of screening for BRCA-associated cancers in rural public health clinics
['FUNDING_R37'] · EMORY UNIVERSITY · NIH-11092823
This project aims to make it easier for more women, especially those in rural areas, to get screened for their family history of BRCA-associated cancers and access follow-up care.
Quick facts
| Phase | ['FUNDING_R37'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11092823 on ClinicalTrials.gov |
What this research studies
We are working to improve an existing family history screening process for cancers linked to BRCA mutations, focusing on making it more accessible and effective for women who have historically been overlooked. This involves adapting the current program to reach more people in rural public health clinics and ensuring that communication about cancer risk is clear and helpful. Our goal is to increase the number and diversity of women who receive these important assessments and connect them with appropriate follow-up services based on their risk.
Who could benefit from this research
Good fit: Ideal candidates for this type of screening program would be women, particularly those who are uninsured, Black, or living in rural areas, who may have a family history of BRCA-associated cancers.
Not a fit: Patients without a family history of BRCA-associated cancers or those already receiving comprehensive genetic counseling and screening may not directly benefit from this specific program adaptation.
Why it matters
Potential benefit: If successful, this work could help more women understand their risk for BRCA-associated cancers and receive timely follow-up care, potentially leading to earlier detection or prevention.
How similar studies have performed: Brief, low-cost family history screening assessments for BRCA-associated cancers are endorsed by national guidelines, but this project focuses on adapting and improving their reach and uptake in underserved populations.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GUAN, YUE — EMORY UNIVERSITY
- Study coordinator: GUAN, YUE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer Risk Factor, Cancers